Results
|
|
7821.
|
|
|
|
7822.
|
|
|
|
7823.
|
|
|
|
7824.
|
|
|
|
7825.
|
|
|
|
7826.
|
|
|
|
7827.
|
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes. [electronic resource] by
- Lamba, Jatinder K
- Crews, Kristine R
- Pounds, Stanley B
- Cao, Xueyuan
- Gandhi, Varsha
- Plunkett, William
- Razzouk, Bassem I
- Lamba, Vishal
- Baker, Sharyn D
- Raimondi, Susana C
- Campana, Dario
- Pui, Ching-Hon
- Downing, James R
- Rubnitz, Jeffrey E
- Ribeiro, Raul C
Producer: 20110720
In:
Pharmacogenomics vol. 12
Availability: No items available.
|
|
|
7828.
|
|
|
|
7829.
|
|
|
|
7830.
|
|
|
|
7831.
|
Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline. [electronic resource] by
- Fukushima, Toshihiro
- Kawabata, Hiroshi
- Sawaki, Toshioki
- Satoh, Tomomi
- Nakamura, Takuji
- Iwao, Haruka
- Nakajima, Akio
- Sakai, Tomoyuki
- Miki, Miyuki
- Fujita, Yoshimasa
- Tanaka, Masao
- Kawanami, Takafumi
- Masaki, Yasufumi
- Okazaki, Toshiro
- Umehara, Hisanori
Producer: 20120524
In:
Anticancer research vol. 32
Availability: No items available.
|
|
|
7832.
|
|
|
|
7833.
|
|
|
|
7834.
|
|
|
|
7835.
|
Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004. [electronic resource] by
- Creutzig, U
- Dworzak, M
- Zimmermann, M
- Bourquin, J-P
- Gruhn, B
- Fleischhack, G
- Graf, N
- Klingebiel, T
- Kremens, B
- Lehrnbecher, T
- von Neuhoff, C
- von Stackelberg, A
- Stray, J
- Reinhardt, D
Producer: 20160314
In:
Klinische Padiatrie vol. 227
Availability: No items available.
|
|
|
7836.
|
Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms. [electronic resource] by
- Devillier, Raynier
- Raffoux, Emmanuel
- Rey, Jérôme
- Lengline, Etienne
- Ronchetti, Anne-Marie
- Sebert, Marie
- Boissel, Nicolas
- Robin, Marie
- Vey, Norbert
- Kiladjian, Jean-Jacques
- Dombret, Herve
- Cluzeau, Thomas
Producer: 20160621
In:
British journal of haematology vol. 172
Availability: No items available.
|
|
|
7837.
|
|
|
|
7838.
|
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. [electronic resource] by
- Döhner, Hartmut
- Müller-Tidow, Carsten
- Lübbert, Michael
- Fiedler, Walter
- Krämer, Alwin
- Westermann, Jörg
- Bug, Gesine
- Schlenk, Richard F
- Krug, Utz
- Goeldner, Rainer-Georg
- Hilbert, James
- Taube, Tillmann
- Ottmann, Oliver G
Producer: 20200504
In:
British journal of haematology vol. 185
Availability: No items available.
|
|
|
7839.
|
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation. [electronic resource] by
- Tsang, Erica S
- Villa, Diego
- Loscocco, Federica
- Visani, Giuseppe
- Power, Maryse
- Guiducci, Barbara
- Clissa, Cristina
- Song, Kevin
- Toze, Cynthia
- Abou Mourad, Yasser
- Sutherland, Heather
- Sanford, David
- Nantel, Stephen H
- Sehn, Laurie H
- Scott, David W
- Savage, Kerry J
- Connors, Joseph M
- Gerrie, Alina S
- Isidori, Alessandro
Producer: 20200416
In:
Bone marrow transplantation vol. 54
Availability: No items available.
|
|
|
7840.
|
The economic impact of the transition from branded to generic oncology drugs. [electronic resource] by
- Cheung, W Y
- Kornelsen, E A
- Mittmann, N
- Leighl, N B
- Cheung, M
- Chan, K K
- Bradbury, P A
- Ng, R C H
- Chen, B E
- Ding, K
- Pater, J L
- Tu, D
- Hay, A E
Producer: 20200331
In:
Current oncology (Toronto, Ont.) vol. 26
Availability: No items available.
|